Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Ranchi"

149 News Found

Neuberg Pulse partners with Dhoni to launch diagnostics centre in Ranchi
Healthcare | July 21, 2025

Neuberg Pulse partners with Dhoni to launch diagnostics centre in Ranchi

Neuberg group commits to invest over Rs. 100 crores to start diagnostics facilities across Jharkhand in the next 2-3 years


Paras Healthcare introduces radiation oncology facility at Ranchi
Healthcare | April 23, 2025

Paras Healthcare introduces radiation oncology facility at Ranchi

The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home


Sure Med Compliance partners with Galt Phranchise Systems to support better outcomes in pain patients
News | June 03, 2023

Sure Med Compliance partners with Galt Phranchise Systems to support better outcomes in pain patients

Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk


Lupin Diagnostics launches its first reference laboratory in Ranchi
Clinical Trials | July 19, 2022

Lupin Diagnostics launches its first reference laboratory in Ranchi

Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies


Shalby Hospital opens its first orthopaedic and joint replacement franchisee in Udaipur, Rajasthan
Hospitals | September 13, 2021

Shalby Hospital opens its first orthopaedic and joint replacement franchisee in Udaipur, Rajasthan

The hospital through its network performs more than 10,000 joint replacement surgeries annually


Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients
News | March 20, 2026

Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients

India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease


BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies
News | March 14, 2026

BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies

The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission


Vertex Pharmaceuticals’ new kidney drug shows dramatic results in Phase 3 trial
Clinical Trials | March 12, 2026

Vertex Pharmaceuticals’ new kidney drug shows dramatic results in Phase 3 trial

The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36


Merck delivers resilient 2025 performance despite global headwinds
News | March 06, 2026

Merck delivers resilient 2025 performance despite global headwinds

Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results